BNTX · earnings call history
BioNTech Q2 FY26 — Leadership Transition and Pipeline Advancement Amidst Revised Guidance
Read the briefBioNTech Q1 FY26 — Oncology Pipeline Advancement and Share Buyback
Read the briefBioNTech Q4 FY25 — Strong Financials and Strategic Pipeline Advancement Amidst Leadership Transition
Read the briefBrowse all US companies on the earnings-call register.